Reported results
- Reported diluted EPS was $1.51, while adjusted diluted EPS was $1.52 for the third quarter of 2026.
- Net revenues increased 1.0% to $6,132 million, and revenues net of excise taxes increased 3.6% to $5,441 million in the third quarter of 2026.
- Smokeable products segment reported adjusted OCI increased 3.9% to $3,072 million, with adjusted OCI margins of 64.5% for the third quarter of 2026.
- Oral tobacco products segment reported adjusted OCI decreased 3.7% to $443 million, with adjusted OCI margins of 66.4% for the third quarter of 2026.
- The company repurchased 5.9 million shares for a total cost of $400 million during the third quarter of 2026.
Guidance
- 2026 full-year adjusted diluted EPS in a range of $5.66 to $5.74.
Notes
The company uses a one-quarter lag for reporting results from its investments in ABI and Cronos. Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.
Price and volatility reaction
The stock moved +5.2% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -4.8 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 72.99 | 2026-10-28 |
| Close after release | 76.75 | 2026-10-29 |
| Realised move | +5.2% | close to close |
| 30d ATM IV change | -4.8 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.
